DE602005020165D1 - Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin - Google Patents

Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin

Info

Publication number
DE602005020165D1
DE602005020165D1 DE602005020165T DE602005020165T DE602005020165D1 DE 602005020165 D1 DE602005020165 D1 DE 602005020165D1 DE 602005020165 T DE602005020165 T DE 602005020165T DE 602005020165 T DE602005020165 T DE 602005020165T DE 602005020165 D1 DE602005020165 D1 DE 602005020165D1
Authority
DE
Germany
Prior art keywords
amino acid
acid sequence
ornithin
citrulline
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020165T
Other languages
English (en)
Inventor
Masato Ikeda
Tetsuo Nakano
Satoshi Mitsuhashi
Mikiro Hayashi
Kenji Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Hakko Bio Co Ltd
Original Assignee
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co Ltd filed Critical Kyowa Hakko Bio Co Ltd
Publication of DE602005020165D1 publication Critical patent/DE602005020165D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/10—Citrulline; Arginine; Ornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
    • C12Y207/02008—Acetylglutamate kinase (2.7.2.8)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005020165T 2004-09-28 2005-09-28 Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin Active DE602005020165D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004280855 2004-09-28
PCT/JP2005/017877 WO2006035831A1 (ja) 2004-09-28 2005-09-28 Ｌ－アルギニン、ｌ－オルニチンまたはｌ－シトルリンの製造法

Publications (1)

Publication Number Publication Date
DE602005020165D1 true DE602005020165D1 (de) 2010-05-06

Family

ID=36118977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020165T Active DE602005020165D1 (de) 2004-09-28 2005-09-28 Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin

Country Status (9)

Country Link
US (1) US7741081B2 (de)
EP (1) EP1801206B1 (de)
JP (1) JP4881739B2 (de)
CN (1) CN101027389B (de)
AT (1) ATE462000T1 (de)
BR (1) BRPI0516176B1 (de)
DE (1) DE602005020165D1 (de)
ES (1) ES2340405T3 (de)
WO (1) WO2006035831A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010041920A (ja) 2006-12-19 2010-02-25 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
JP2010130899A (ja) 2007-03-14 2010-06-17 Ajinomoto Co Inc Ｌ−グルタミン酸系アミノ酸生産微生物及びアミノ酸の製造法
US8692070B2 (en) 2009-11-04 2014-04-08 Iowa Corn Promotion Board Plants with improved nitrogen utilization and stress tolerance
JP5875869B2 (ja) * 2009-12-17 2016-03-02 Ｍｃフードスペシャリティーズ株式会社 アルギニン高含有酵母エキスおよびその製造方法
DE102010003419B4 (de) * 2010-03-30 2019-09-12 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von L-Ornithin
CN101863801A (zh) * 2010-06-12 2010-10-20 徐州医学院 一种光学活性瓜氨酸或高瓜氨酸的制备方法
KR101372635B1 (ko) 2010-12-08 2014-03-13 씨제이제일제당 (주) 오르니틴 생산능이 향상된 미생물 및 이를 이용하여 오르니틴을 생산하는 방법
US9567616B2 (en) 2011-02-09 2017-02-14 Kyowa Hakko Bio Co., Ltd. Process for producing target substance by fermentation
RU2496867C2 (ru) 2011-04-25 2013-10-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Способ получения l-аминокислоты семейства глутамата с использованием коринеформной бактерии
BR112013016373B1 (pt) 2011-11-11 2021-05-18 Ajinomoto Co., Inc método para produzir uma substância alvo
US20150118720A1 (en) * 2012-04-13 2015-04-30 Kyowa Hakko Bio Co., Ltd. Process for producing amino acid
WO2014185430A1 (ja) 2013-05-13 2014-11-20 味の素株式会社 Ｌ－アミノ酸の製造法
JP2016165225A (ja) 2013-07-09 2016-09-15 味の素株式会社 有用物質の製造方法
JP2016192903A (ja) 2013-09-17 2016-11-17 味の素株式会社 海藻由来バイオマスからのｌ−アミノ酸の製造方法
JP6459962B2 (ja) 2013-10-21 2019-01-30 味の素株式会社 Ｌ−アミノ酸の製造法
EP3061828A4 (de) 2013-10-23 2017-03-15 Ajinomoto Co., Inc. Verfahren zur herstellung einer zielsubstanz
CN104031933A (zh) * 2014-05-08 2014-09-10 江南大学 一株l-鸟氨酸合成菌的构建及其应用方法
KR101835935B1 (ko) 2014-10-13 2018-03-12 씨제이제일제당 (주) L-아르기닌을 생산하는 코리네박테리움 속 미생물 및 이를 이용한 l-아르기닌의 제조 방법
BR112017011923A2 (pt) * 2014-12-05 2018-02-27 Synlogic Inc bactéria modificada para tratar doenças associadas com hiperamonemia
CN105017086B (zh) * 2015-07-01 2017-05-03 滨州市生物技术研究院有限责任公司 一种l‑瓜氨酸分离纯化的方法
JP6623690B2 (ja) 2015-10-30 2019-12-25 味の素株式会社 グルタミン酸系ｌ−アミノ酸の製造法
CN110195088B (zh) * 2018-02-26 2022-09-27 中国科学院分子植物科学卓越创新中心 一种精氨酸水解酶及其编码基因和应用
CN111394295B (zh) * 2019-11-06 2023-03-10 上海健康医学院 一种制备固定化精氨酸脱亚胺酶及生产[14/15n]-l-瓜氨酸的方法
KR102433234B1 (ko) * 2020-09-29 2022-08-18 대상 주식회사 L-시트룰린 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-시트룰린의 생산 방법
KR20240013961A (ko) * 2022-07-21 2024-01-31 대상 주식회사 L-아르기닌 또는 l-시트룰린 생산능이 향상된 코리네박테리움 속 미생물 및 이를 이용한 l-아르기닌 또는 l-시트룰린의 생산 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755155B2 (ja) 1986-09-10 1995-06-14 協和醗酵工業株式会社 アミノ酸の製造法
JPH0728749B2 (ja) * 1986-09-22 1995-04-05 協和醗酵工業株式会社 Ｌ−アルギニンの製造法
MXPA01012932A (es) * 1999-07-01 2002-07-30 Basf Ag Genes de corynebacterium glutamicum que codifican proteinas de sistema de fosfoenolpiruvato: azucar fosfotransferasa.
US7160705B2 (en) 2000-04-28 2007-01-09 Ajinomoto Co., Inc. Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine
JP2002051790A (ja) * 2000-04-28 2002-02-19 Ajinomoto Co Inc コリネ型細菌のアルギニンリプレッサー欠失株及びｌ−アルギニンの製造法
AU2002247644A1 (en) * 2001-02-16 2002-09-04 Degussa Ag Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum
DE10154292A1 (de) * 2001-11-05 2003-05-15 Basf Ag Gene die für Stoffwechselweg-Proteine codieren

Also Published As

Publication number Publication date
WO2006035831A1 (ja) 2006-04-06
US20090123980A1 (en) 2009-05-14
JP4881739B2 (ja) 2012-02-22
EP1801206A4 (de) 2009-01-14
EP1801206A1 (de) 2007-06-27
ATE462000T1 (de) 2010-04-15
BRPI0516176B1 (pt) 2020-12-29
JPWO2006035831A1 (ja) 2008-05-15
CN101027389A (zh) 2007-08-29
CN101027389B (zh) 2012-09-26
US7741081B2 (en) 2010-06-22
EP1801206B1 (de) 2010-03-24
ES2340405T3 (es) 2010-06-02
BRPI0516176A (pt) 2008-08-26

Similar Documents

Publication Publication Date Title
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
IN2014CN02050A (de)
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE417595T1 (de) Keratin-bindende polypeptide
NZ600690A (en) Fkbp-l and uses thereof
RS52537B (en) ACTIVIN-ACTRII ANTAGONISTS AND USES FOR ANEMIA TREATMENT
DE60333963D1 (de) Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
GB2431404A (en) Peptide
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
ATE477272T1 (de) Verwendung von stefin a als gerüstprotein
RU2015118580A (ru) НОВЫЙ ВЫСОКО ФУНКЦИОНАЛЬНЫЙ ФЕРМЕНТ, ИМЕЮЩИЙ МОДИФИЦИРОВАННУЮ СУБСТРАТНУЮ СПЕЦИФИЧНОСТЬ β-ГЕКСОЗАМИНИДАЗЫ ЧЕЛОВЕКА И ПРОЯВЛЯЮЩИЙ УСТОЙЧИВОСТЬ К ПРОТЕАЗЕ
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DK2289533T3 (da) Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
ATE323763T1 (de) Dna & protein bindende miniatur proteine
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
GB0524884D0 (en) Improvements in or relating to organic compounds
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
HK1147210A1 (en) Anti-hypertensive agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition